Primary virus infection often elicits a large CD8+ T cell response which subsequently contracts to a smaller memory T cell pool; the relationship between these two virus-specific populations is not well understood. Here we follow the human CD8+ T cell response to Epstein-Barr virus (EBV) from its primary phase in infectious mononucleosis (IM) through to the persistent carrier state. Using HLA-A2.1 or B8 tetramers specific for four lytic cycle and three latent cycle epitopes, we find marked differences in the epitope-specific composition of the T cell populations between the two phases of infection. The primary response is dominated by lytic epitope specificities which are severely culled (and in one case extinguished) with resolution of the acute infection; in contrast latent epitope specificities are less abundant, if present at all, in acute IM but often then increase their percentage representation in the CD8 pool. Even comparing epitopes of the same type, the relative size of responses seen in primary infection does not necessarily correlate with that seen in the longer term. We also follow the evolution of phenotypic change in these populations and show that, from a uniform CD45RA−RO+CCR7− phenotype in IM, lytic epitope responses show greater reversion to a CD45RA+RO− phenotype whereas latent epitope responses remain CD45RA−RO+ with a greater tendency to acquire CCR7. Interestingly these phenotypic distinctions reflect the source of the epitope as lytic or latent, and not the extent to which the response has been amplified in vivo.
Skip Nav Destination
Article navigation
1 April 2002
Article|
April 01 2002
Epitope-specific Evolution of Human CD8 + T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection
Andrew D. Hislop,
Andrew D. Hislop
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Nicola E. Annels,
Nicola E. Annels
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Nancy H. Gudgeon,
Nancy H. Gudgeon
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Alison M. Leese,
Alison M. Leese
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Alan B. Rickinson
Alan B. Rickinson
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Andrew D. Hislop
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Nicola E. Annels
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Nancy H. Gudgeon
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Alison M. Leese
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Alan B. Rickinson
CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
Address correspondence to Professor A.B. Rickinson, CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Phone: 44-121-414-4492; Fax: 44-121-414-4486; E-mail: [email protected]
A.D. Hislop and N.E. Annels contributed equally to this work.
*
Abbreviations used in this paper: EBNA, EBV nuclear antigen; Elispot, enzyme-linked immunospot; IM, infectious mononucleosis; LCL, B lymphoblastoid cell line.
Received:
October 08 2001
Revision Received:
January 07 2002
Accepted:
February 07 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (7): 893–905.
Article history
Received:
October 08 2001
Revision Received:
January 07 2002
Accepted:
February 07 2002
Citation
Andrew D. Hislop, Nicola E. Annels, Nancy H. Gudgeon, Alison M. Leese, Alan B. Rickinson; Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection . J Exp Med 1 April 2002; 195 (7): 893–905. doi: https://doi.org/10.1084/jem.20011692
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement